Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-037200
Filing Date
2025-03-11
Accepted
2025-03-11 16:30:06
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5739
  Complete submission text file 0000950170-25-037200.txt   7166
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Issuer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO CA 94080
Business Address
Schilke Tobin (Reporting) CIK: 0001678984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38583 | Film No.: 25728039